Natural tannin extracts supplementation for COVID-19 patients (TanCOVID): a structured summary of a study protocol for a randomized controlled trial
COVID-19 환자를 위한 천연 탄닌 추출물 보충제(TanCOVID): 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
24 hour
24 hours
addition
Administered
administration
affected
age
All trial participants
all-cause mortality
Alpha
alpha error
Antibiotic therapy
antipyretics
assigned
assisted ventilation
Azithromycin
B12
blinded
Blinding
branch
Buenos Aire
Buenos Aires
can not
Chestnut tannins
Clinical symptoms
clinical trial
closure
cognitive
computer-generated random numbering
conditions
Consent
control group
COVID-19
COVID-19 patient
criteria
cytokine
Cytokines
Day
Decline
decrease
defined
Definition
Department
described
diagnosis of SARS-CoV-2
dietary supplement
difference
disease
dissemination
dose
double-blind
Efficacy
element
eligibility
eligible
enrolled
Enrollment
enrolment
epidemiological
evaluate
excluded
fecal
Final
first dose
first visit
Gender
gut microbiota
Hospital de Clínica
Hospital de Clínicas
Hospital de Clinicas Jose de San Martin
hospital discharge
Hydroxychloroquine
hypersensitivity
ICU
impaired consciousness
increase in
indicated
Infection
Infectious disease
Infectious diseases
Inflammation
inflammatory mediator
Inflammatory mediators
Informed consent
intestinal
intestinal permeability
invasive ventilation
lactating
Level
Lopinavir
mean difference
measure
mechanical ventilation
mediators
microbiota
modifications
molecular
natural
non-invasive ventilation
number
objective
Older
outcome
parallel-group
parameter
participant
Participation
Patient
patients
per day
Placebo
placebo-controlled
platform
Potential
power
power of 80%
protocol
Quebracho tannins
randomization
Randomized
Randomized controlled trial
Randomly
Real-time PCR
receive
recruited
recruitment
Registered
Research
Ritonavir
Sample size
SARS-COV-2 infection
SARS-CoV2
screened
secondary
secondary outcome measures
severity
Standard therapy
standard treatment
status
study participant
Study protocol
study randomization
submitted
supplementary material
supply
tannin
tannins
therapy
time
Time frame
took place
Treatment
treatment allocation
Trial
trial participant
Trial registration
undergo
university
Ventilation
website
[DOI] 10.1186/s13063-021-05281-x PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-021-05281-x PMC 바로가기 [Article Type] Letter